Pod C

Tamara Alliston, PhD studies the mechanobiologic mechanisms supporting skeletal health and driving arthritis, osteoporosis, and bone fragility.

Kelsey Collins, PhD, uses induced pluripotent stem cells, CRISPR-Cas9 genome engineering, mouse models, human tissues, and state-of-the-art multi-omic spatial approaches to define mechanisms and create therapies that have implications for aging, obesity, diabetes, and other chronic diseases.

Marlys Fassett, MD, PhD is a dermatologist and physician-scientist studying the neuroimmune circuits that couple itch and rash. 

Michael German, MD studies the cascade of gene activation underlying the development of beta cells from less differentiated cells during embryogenesis or from stem cells in the adult pancreas, and how these genes function in the mature beta cell.

Carolyn Sangokoya MD, PhD is a physician-scientist, RNA biologist, and liver pathologist studying RNA and metabolic networks driving cell fate, function, and plasticity. Her lab builds and uses molecular tools to evaluate, re-engineer, and re-wire cell fates for targeted plasticity and regenerative medicine.

Julie Sneddon, PhD studies pancreatic development and type I diabetes, employing the tools of stem cell biology, developmental biology, genomics and tissue engineering.